Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005477-99-003430
Filing Date
1999-08-06
Accepted
1999-08-06 00:00:00
Documents
1
Period of Report
1999-08-30

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT DEF 14A 52004
  Complete submission text file 0001005477-99-003430.txt   53493
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-13341 | Film No.: 99678911
SIC: 2836 Biological Products, (No Diagnostic Substances)